Last Updated: July 06, 2026
Most wellness brands stall launches because their marketing team doesn't understand FDA constraints. Get a growth leader who has navigated regulatory requirements before – and actually moved the revenue needle.
The Problem
FDA and FTC compliance gaps turn every launch into a legal review cycle
Your product works, but marketing can't make the claims that drive conversions. Without regulatory experience on the marketing side, every campaign goes back to legal for review. Teams that haven't launched health products before consistently underestimate claim substantiation requirements, adding months to go-to-market. The result is a slowed pipeline and budget that burns while approvals drag.
Wellness consumer skepticism drives up CAC for brands without clinical proof
Years of unsubstantiated wellness claims have made consumers cautious. If your acquisition strategy relies on lifestyle positioning alone, you're fighting for attention on the same dimension as every competitor. Brands that integrate clinical evidence into their messaging shorten the trust-building cycle. Without that, you're paying more to convert less-qualified buyers.
Health brand trust is fragile – one bad cycle erodes retention fast
High-consideration health purchases depend on repeat trust, not one-time conversion. When messaging overpromises or fails to align with product reality, LTV collapses faster than you expect. Digital-first health brands are especially exposed because they lack the in-person credibility signals that retail provides. Recovery from a trust failure takes longer than building trust correctly the first time.
How We Help
We embed with your team and build a growth system calibrated to regulatory reality – not a theoretical marketing plan that falls apart the first time legal reviews a campaign. Health and wellness companies need senior operators who already know what claims are defensible, how to integrate clinical evidence into conversion copy, and where acquisition channels actually scale in this space.
The assessment phase starts with your compliance framework and clinical data inventory. We map what you can say, what you cannot, and where the gaps are between your evidence base and your current messaging. This tells us exactly where you are leaving trust – and conversions – on the table.
Strategy development builds a growth roadmap specific to your channel mix and customer profile. For health companies, this typically means a heavier emphasis on earned media, clinical content, and third-party validation than most verticals. Our growth strategy work connects positioning directly to acquisition economics.
Execution is embedded – not advisory. We manage agency relationships, review creative for compliance before it goes to legal, and make resource allocation decisions alongside your team. You get marketing leadership that attends your standups, not a consultant who shows up for monthly reviews.
Measurement is set up before we change anything. Baseline metrics go in on day one so every result is tracked against real starting points. If your measurement infrastructure needs rebuilding, that is part of the engagement – not a prerequisite.
What we deliver
- FDA-compliant go-to-market strategy – built to move fast without triggering legal review delays
- Clinical evidence integration framework – turn your data into conversion assets, not liability
- Trust-building content system – structured to drive repeat purchase and reduce churn
- Channel strategy scoped to health-specific acquisition economics
Regulatory constraints in health marketing are not a barrier to growth – they are a filter that eliminates competitors who can't navigate them. Brands that build compliance fluency into their marketing function move faster than everyone else once they're past the learning curve.
Our Methodology
The 90-day sprint is structured to create measurable progress at each phase gate. Days 1-30 are diagnostic: we audit your analytics stack, map the customer journey from first touch through repeat purchase, and identify the three to five highest-leverage changes. We also establish baseline metrics against which every downstream result is measured.
Days 30-60 shift to strategy and early execution. We build the prioritized growth roadmap, begin restructuring channels or team roles where the audit identified gaps, and start executing quick wins. For health companies, this phase often involves rebuilding the relationship between marketing and regulatory review so approvals stop being a bottleneck.
Days 60-90 are full execution. Systems are running, the team has clear ownership, and we are optimizing based on live performance data. By end of sprint, you have a functioning growth engine with documented processes – one that works whether we extend the engagement or not.
How We Work
The first 30 days are diagnostic. We audit your marketing infrastructure, interview key stakeholders, review your clinical evidence assets, and map the compliance boundaries that constrain your current campaigns. This phase ends with a prioritized opportunity list and baseline metrics.
Days 30-60 move into strategy and early execution. We build the growth roadmap, begin channel restructuring where needed, and start implementing the changes with the highest near-term payoff. Weekly check-ins keep the team aligned and leadership informed.
Days 60-90 are full execution and optimization. We are in your standups, managing agency relationships, reviewing creative for compliance, and making resource allocation calls. Monthly strategy reviews go to the leadership team with plain-language reporting on what is working and what is changing.
Most health and wellness engagements run 3-6 months at 15-25 hours per week embedded with your team. The goal is to build systems that outlast the engagement – not create a dependency.
- Faster launch timelines through integrated compliance review
- Lower CAC via clinical evidence-based positioning
- Improved LTV through trust-building content systems
- Channel diversification beyond paid acquisition
If your health & wellness company needs fractional cxo leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
How much does a fractional CXO engagement cost for health and wellness companies?
Engagements typically run $18K-$28K per month depending on regulatory complexity, clinical evidence requirements, and execution scope. That covers 15-25 hours per week of embedded senior leadership. Compare that to a full-time CMO at $350K-$450K all-in, plus the ramp time for someone who hasn't navigated health compliance before. The fractional model gives you operator-level expertise without long-term overhead. Most clients see the cost offset in the first 90 days through faster time-to-launch alone.
Do you handle FDA and FTC compliance directly?
We are not regulatory consultants and do not replace your legal team. What we do is build marketing strategies that work within your compliance constraints from the start – so campaigns don't get killed in legal review. We have launched health products across multiple categories and know what claims are defensible, what requires substantiation, and what triggers FTC scrutiny. The goal is to stop compliance from being a bottleneck and start treating it as a competitive filter that your slower competitors can't get past.
How do you integrate clinical evidence into marketing without overstating results?
Clinical data is most powerful when it builds trust, not when it makes therapeutic claims. We position evidence as proof of mechanism and transparency – showing consumers what you measured, how, and what it means – rather than outcome promises that invite regulatory review. This approach consistently outperforms pure lifestyle positioning in health verticals because it gives skeptical consumers something specific to evaluate. It also shortens legal review cycles because you are not pushing claim boundaries.
What makes Winston Francois different from a traditional health marketing agency?
Agencies build campaigns. We build growth systems. The difference is ownership – we embed with your team, attend your leadership meetings, and own the number alongside you. Most health marketing agencies lack senior operators who have actually run growth at a health company. We bring that experience into your team structure without the overhead of a full-time executive hire. You get someone who has already made the expensive mistakes in this vertical – on someone else's timeline.
How do you measure ROI on a fractional CXO engagement?
We establish baseline metrics on day one so every result has a clear before-and-after. The metrics we track depend on your stage: early-stage companies typically focus on CAC and conversion rate by channel; growth-stage companies add LTV, payback period, and channel concentration risk. Monthly reporting connects every initiative to a revenue outcome. If something is not moving a number that matters, we stop doing it. Vanity metrics are not part of the reporting stack.
What type of health or wellness company is the right fit for this engagement?
The engagements that work best are companies that have product-market fit and are now trying to scale acquisition and retention efficiently. Typically that is post-seed through Series B, or bootstrapped companies hitting a growth ceiling. You need a functioning product, some customer data to work from, and leadership that is willing to make decisions based on what the data shows. If you are still validating the product, that is a different kind of engagement than what we do.
